EUVIMEDEUVIMED entdecken
Crossref

The clinicopathological and molecular features of primary high‐grade neuroendocrine tumour in the breast

Ruping Hong iD, Hao Wang iD, Yan Lin iD, Xianglin Yin iD, Jiuyuan Fang iD, Junyi Pang iD, Longyun Chen iD, Huanwen Wu iD, Zhiyong Liang iD

Histopathology · 2025-05 · 86 (6) · 900-915

DOI: 10.1111/his.15398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 17.12.2024. Verfasst von Ruping Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Un…. Hauptthemen laut MEDLINE: Breast Neoplasms, Neuroendocrine Tumors, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Nottingham grade for breast cancers, rather than gastro‐entero‐pancreatic (GEP) grade for neuroendocrine tumours (NETs), is currently applied to primary breast NETs, which need further clarification. High‐grade NETs in breast also remain poorly recognised. Methods and results Among 595 breast carcinomas with diffuse synaptophysin (Syn) or chromogranin A (CgA) immunostaining (≥ 90%), 197 eligible cases were selected, including 69 NETs, 123 invasive breast carcinomas of no special type (IBC‐NSTs) and five neuroendocrine carcinomas (NECs). The prognostic significance of these two grading systems in breast NETs was assessed. Furthermore, the clinicopathological features were compared in Nottingham G3 cases among three entities. Targeted sequencing and immunostaining (INSM1/p53/Rb/p16) were also performed in all Nottingham G3 NETs, NECs and 10 Nottingham G3 IBC‐NSTs. All Nottingham G3 NETs (9 of 69, 13.0%) fell into GEP G3 cases (20 of 69, 29.0%). Nottingham grade provided better prognostic discrimination between G1/G2 and G3 NETs than GEP grade. Among Nottingham G3 cases, there was a trend towards reduced progression‐free survival (PFS) in NETs compared with IBC‐NSTs ( P = 0.057), and the former were more often immunoreactive for INSM1 (44.4 versus 0%, P = 0.033). Nottingham G3 NETs were all of luminal‐like phenotype ( P < 0.001) and exhibited less aberrant p53 patterns (11.1 versus 80.0%, P = 0.023) as well as more favourable PFS ( P = 0.012) and disease‐specific survival ( P = 0.002) than NECs. Rb loss (4 of 5, 80%), p16 overexpression (5 of 5, 100%) and RB1 mutation (2 of 5, 40%) were observed exclusively in NECs. Based on expression data, epithelial–mesenchymal transition and KRAS signalling pathways were significantly up‐regulated in Nottingham G3 NETs ( P < 0.05).

Conclusions

Nottingham grade, rather than GEP grade, holds important prognostic significance in primary breast NETs. Nottingham G3 NETs represent a small proportion of breast NETs, and may demonstrate distinct clinicopathological and molecular features from other high‐grade breast carcinomas with diffuse neuroendocrine markers expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeuroendocrine TumorsCarcinoma, NeuroendocrineHumansFemaleMiddle AgedAdultAgedNeoplasm GradingBiomarkers, TumorPrognosisAged, 80 and over

Stichwörter der Autor:innen

breasthigh‐gradeneuroendocrineneuroendocrine tumour

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

ORCID-Profile: Ruping Hong, Hao Wang, Yan Lin, Xianglin Yin, Jiuyuan Fang, Junyi Pang, Longyun Chen, Huanwen Wu, Zhiyong Liang

Förderung

  • Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS)
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Hong, R., Wang, H., Lin, Y., Yin, X., Fang, J., Pang, J., Chen, L., Wu, H., & Liang, Z. (2025). The clinicopathological and molecular features of primary high‐grade neuroendocrine tumour in the breast. Histopathology, 86(6), 900-915. https://doi.org/10.1111/his.15398

Vancouver

Hong R, Wang H, Lin Y, Yin X, Fang J, Pang J, et al. The clinicopathological and molecular features of primary high‐grade neuroendocrine tumour in the breast. Histopathology. 2025;86(6):900-915. doi:10.1111/his.15398

BibTeX
@article{Hong2025,
  author = {Hong, Ruping and Wang, Hao and Lin, Yan and Yin, Xianglin and Fang, Jiuyuan and Pang, Junyi and Chen, Longyun and Wu, Huanwen and Liang, Zhiyong},
  title = {The clinicopathological and molecular features of primary high‐grade neuroendocrine tumour in the breast},
  journal = {Histopathology},
  year = {2025},
  volume = {86},
  number = {6},
  pages = {900--915},
  doi = {10.1111/his.15398}
}
Kostenlos starten →